Last reviewed · How we verify
Metformin-GLP-1 Receptor Agonist — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Metformin-GLP-1 Receptor Agonist (Metformin-GLP-1 Receptor Agonist) — Xinqiao Hospital of Chongqing.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metformin-GLP-1 Receptor Agonist TARGET | Metformin-GLP-1 Receptor Agonist | Xinqiao Hospital of Chongqing | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metformin-GLP-1 Receptor Agonist CI watch — RSS
- Metformin-GLP-1 Receptor Agonist CI watch — Atom
- Metformin-GLP-1 Receptor Agonist CI watch — JSON
- Metformin-GLP-1 Receptor Agonist alone — RSS
Cite this brief
Drug Landscape (2026). Metformin-GLP-1 Receptor Agonist — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-glp-1-receptor-agonist. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab